<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04175509</url>
  </required_header>
  <id_info>
    <org_study_id>2019.08.20.MB</org_study_id>
    <nct_id>NCT04175509</nct_id>
  </id_info>
  <brief_title>Improving Post-Operative Pain and Recovery in Gynecologic Surgery</brief_title>
  <official_title>Improving Post-Operative Pain and Recovery in Gynecologic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aultman Health Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aultman Health Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical investigation to determine the efficacy of rectal versus intravenous&#xD;
      acetaminophen in patients undergoing a minimally invasive hysterectomy. All women will&#xD;
      receive acetaminophen either rectally or intravenously immediately postoperative, prior to&#xD;
      extubation. Patient's will be randomly assigned to either the rectal acetaminophen or the&#xD;
      intravenous acetaminophen group. Patient outcomes will be measured through a Numeric Rating&#xD;
      Scale (NRS) from 0-10 for pain scores, and total opioid consumption measured in morphine&#xD;
      milligram equivalent (MME) for the first 24 hours following surgery, or upon discharge,&#xD;
      whichever comes first.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patient's undergoing major gynecologic surgery require effective postoperative pain&#xD;
      management in order to enhance recovery and ultimately allow patients to return to their&#xD;
      preoperative functional state. Traditionally, acute postoperative pain control has been&#xD;
      achieved largely with the use of opioid medications. Excessive use of opioids can have&#xD;
      adverse effects on the recovery process. Side effects include, but are not limited to&#xD;
      dizziness, sedation, nausea/vomiting, respiratory depression, euphoria, constipation, and&#xD;
      abuse. In addition, opioid monotherapy can delay post-operative ambulation, contribute to&#xD;
      prolonged hospital stay and resumption of activities of daily living, and furthermore, have&#xD;
      long-term sequelae for individuals as well as society at whole.&#xD;
&#xD;
      Over the past decade, a multimodal approach to pain management has been explored in attempts&#xD;
      to optimally treat acute postoperative pain. This approach is one of the keys to improving&#xD;
      the recovery process.&#xD;
&#xD;
      Acetaminophen is a non-opioid analgesic with a well-established safety and tolerability&#xD;
      profile that is commonly used in multimodal approach to treating surgical pain. It is&#xD;
      available in oral, rectal and Intravenous (IV) formulation. IV acetaminophen in particular is&#xD;
      increasingly used for pain control after surgery as it has demonstrated a significant&#xD;
      analgesic benefit in a variety of surgery types by reduction in pain intensity while&#xD;
      decreasing total opioid use. Many studies have evaluated the efficacy of acetaminophen based&#xD;
      on route of administration. A systematic review demonstrated that there is no clear&#xD;
      indication for intravenous acetaminophen for patients who can tolerate an oral dosage as&#xD;
      there was no difference if efficacy outcomes. This is valuable information as the cost of IV&#xD;
      acetaminophen is exponentially more than the oral form. Although the oral form of&#xD;
      acetaminophen is as efficient as controlling pain when compared to IV, and is notably&#xD;
      cheaper, it is not the best option for the nauseated patient or patients whom are restricted&#xD;
      from oral intake following surgery. Rectal acetaminophen is therefore a feasible alternative&#xD;
      option in such patients.&#xD;
&#xD;
      Data on the use of rectal acetaminophen in adults for postoperative pain management is&#xD;
      limited. Pettersson and colleagues (2005) compared oral, rectal and IV paracetamol in day&#xD;
      surgery patients. Although they demonstrated significantly higher plasma paracetamol&#xD;
      concentrations in patients who received oral and IV formations at multiple time points, there&#xD;
      was no difference in pain ratings. In another study, rectal paracetamol was shown to have a&#xD;
      significant morphine-sparing effect after hysterectomy.&#xD;
&#xD;
      At this time, there has been no study in the gynecologic literature to compare IV to rectal&#xD;
      acetaminophen in terms of pain control and effect on overall opioid use in the acute&#xD;
      post-operative period.&#xD;
&#xD;
      The rationale for this study is to determine the optimal way of managing post-operative pain&#xD;
      in gynecologic surgery in attempt to improve the overall recovery process. More specifically,&#xD;
      this study will determine if the route of administration of acetaminophen has an effect on&#xD;
      post-operative pain and use of opioid medication following a minimally invasive hysterectomy.&#xD;
      The results of this study may guide post-operative pain management after gynecologic surgery,&#xD;
      and help limit the amount of opioid use, while potentially reducing pharmacological costs for&#xD;
      patients and hospitals.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 23, 2019</start_date>
  <completion_date type="Actual">June 1, 2021</completion_date>
  <primary_completion_date type="Actual">June 1, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Pain: Standardized Pain Scale</measure>
    <time_frame>The first 24 hours following surgery, or upon discharge, whichever comes first.</time_frame>
    <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) measured every 4 hours for the 24 hours, or discharge, whichever comes first. Time points were averaged for each participate and reported as a single value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid Use</measure>
    <time_frame>The first 24 hours following surgery, or upon discharge, whichever comes first.</time_frame>
    <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 24 hours following surgery, or upon discharge, whichever comes first.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Postoperative Pain: Standardized Pain Scale</measure>
    <time_frame>The first 6 hours following surgery</time_frame>
    <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) for the first 6 hours after surgery. Time points were averaged for each participate and reported as a single value.</description>
  </other_outcome>
  <other_outcome>
    <measure>Postoperative Pain: Standardized Pain Scale</measure>
    <time_frame>The 12 hours following surgery</time_frame>
    <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) for the first 12 hours after surgery. Time points were averaged for each participate and reported as a single value.</description>
  </other_outcome>
  <other_outcome>
    <measure>Opioid Use</measure>
    <time_frame>The first 6 hours following surgery</time_frame>
    <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 6 hours following surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Opioid Use</measure>
    <time_frame>The first 12 hours following surgery</time_frame>
    <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 12 hours following surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Estimated Blood Loss</measure>
    <time_frame>During the duration of the surgery, from start to end time, on average 1.5 hours</time_frame>
    <description>Total estimated blood loss in millilitres for the surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Operative Time</measure>
    <time_frame>From the start to end of the surgery</time_frame>
    <description>Operative time in minutes determined by the operating room record</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Opioid Use</condition>
  <condition>Acetaminophen</condition>
  <arm_group>
    <arm_group_label>Rectal acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rectal acetaminophen</intervention_name>
    <description>Rectal 1300mg</description>
    <arm_group_label>Rectal acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous acetaminophen</intervention_name>
    <description>Intravenous 1000mg</description>
    <arm_group_label>Intravenous acetaminophen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Willing to consent&#xD;
&#xD;
          -  Amendable to receive either rectal or intravenous acetaminophen&#xD;
&#xD;
          -  Planned hospital stay for at least 24 hours.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unable to provide informed consent&#xD;
&#xD;
          -  Patients with a history of regular opioid use prior to surgery based on their current&#xD;
             home medication list&#xD;
&#xD;
          -  Patients who have required regular opioid intake for the 7 days preceding surgery&#xD;
&#xD;
          -  Patients with known hypersensitivity to acetaminophen&#xD;
&#xD;
          -  Patients with a baseline preoperative liver function enzymes (AST and ALT) that are&#xD;
             greater than twice the upper limits&#xD;
&#xD;
          -  Unable to complete procedure as planned.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cao X, et al. Effect of intraoperative or postoperative intravenous acetaminophen on postoperative pain scores and opioid requirements in abdominal and spinal surgery patients. Int J Clin Exp Med 11(4)4120-4125, 2018.</citation>
  </reference>
  <reference>
    <citation>Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008. Erratum in: J Pain. 2016 Apr;17(4):508-10. Dosage error in article text.</citation>
    <PMID>26827847</PMID>
  </reference>
  <reference>
    <citation>Sconzo Jr FR, Ramamoorthy S. The role of multimodal analgesia in colorectal surgery: a review of clinical data and case-based presentations featuring Ofirmev (acetaminophen) injections. Diseases of the Colon &amp; Rectum 58(2):1-15, 2015.</citation>
  </reference>
  <reference>
    <citation>Jibril F, Sharaby S, Mohamed A, Wilby KJ. Intravenous versus Oral Acetaminophen for Pain: Systematic Review of Current Evidence to Support Clinical Decision-Making. Can J Hosp Pharm. 2015 May-Jun;68(3):238-47. Review.</citation>
    <PMID>26157186</PMID>
  </reference>
  <reference>
    <citation>Petterson PH, Hein A, Owall A, Anderson RE, Jakobsson JG. Early bioavailability in day surgery: a comparison between orally, rectally, and intravenously administered paracetamol. J. of Ambulatory Surgery 12:27-30, 2005.</citation>
  </reference>
  <reference>
    <citation>Cobby TF, Crighton IM, Kyriakides K, Hobbs GJ. Rectal paracetamol has a significant morphine-sparing effect after hysterectomy. Br J Anaesth. 1999 Aug;83(2):253-6.</citation>
    <PMID>10618939</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 21, 2019</study_first_submitted>
  <study_first_submitted_qc>November 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2019</study_first_posted>
  <results_first_submitted>June 4, 2021</results_first_submitted>
  <results_first_submitted_qc>August 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 19, 2021</results_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aultman Health Foundation</investigator_affiliation>
    <investigator_full_name>Michaela Beynon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Postoperative Pain</keyword>
  <keyword>Minimally-invasive Hysterectomy</keyword>
  <keyword>Opioid Use</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Hysterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 12, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT04175509/Prot_SAP_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 28, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT04175509/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Rectal Acetaminophen</title>
          <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
        </group>
        <group group_id="P2">
          <title>Intravenous Acetaminophen</title>
          <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Rectal Acetaminophen</title>
          <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
        </group>
        <group group_id="B2">
          <title>Intravenous Acetaminophen</title>
          <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="36"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.53" spread="13.64"/>
                    <measurement group_id="B2" value="52.37" spread="14.08"/>
                    <measurement group_id="B3" value="51.50" spread="13.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Indication for hysterectomy</title>
          <description>Prior to surgery, the indication for surgery was determined based on either clinical (exam based) or histologic findings (tissue biopsy). Based on the clinical and/or histologic findings, patients were scheduled for a hysterectomy for a benign or malignant indication, as determined by the attending physician</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Benign</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Malignant</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes Mellitus</title>
          <description>Number of participants with a current diagnosis of diabetes mellitus</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <description>Number of participants with a current diagnosis of hypertension</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Thyroid disease</title>
          <description>Number of participants with a current diagnosis of thyroid disease</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pulmonary disease</title>
          <description>Number of participants with a current diagnosis of pulmonary disease</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Anxiety and/or depression</title>
          <description>Number of participants with a current diagnosis of anxiety and/or depression</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Obesity</title>
          <description>Number of participants with a current diagnosis of obesity (BMI &gt;/= 30)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pathology</title>
          <description>Based on the microscopic examination of the tissue, the diagnosis of benign or malignant disease was made by a trained pathologist.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Benign</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Malignant</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Pain: Standardized Pain Scale</title>
        <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) measured every 4 hours for the 24 hours, or discharge, whichever comes first. Time points were averaged for each participate and reported as a single value.</description>
        <time_frame>The first 24 hours following surgery, or upon discharge, whichever comes first.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rectal Acetaminophen</title>
            <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain: Standardized Pain Scale</title>
          <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) measured every 4 hours for the 24 hours, or discharge, whichever comes first. Time points were averaged for each participate and reported as a single value.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.82" spread="1.11"/>
                    <measurement group_id="O2" value="3.18" spread="1.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.378</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Use</title>
        <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 24 hours following surgery, or upon discharge, whichever comes first.</description>
        <time_frame>The first 24 hours following surgery, or upon discharge, whichever comes first.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rectal Acetaminophen</title>
            <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Use</title>
          <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 24 hours following surgery, or upon discharge, whichever comes first.</description>
          <units>Morphine Milligram Equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.75" spread="20.09"/>
                    <measurement group_id="O2" value="23.71" spread="18.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.753</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Postoperative Pain: Standardized Pain Scale</title>
        <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) for the first 6 hours after surgery. Time points were averaged for each participate and reported as a single value.</description>
        <time_frame>The first 6 hours following surgery</time_frame>
        <population>Two participants in the intravenous acetaminophen group were discharged home prior to 6 hours after surgery and therefore were not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Rectal Acetaminophen</title>
            <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain: Standardized Pain Scale</title>
          <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) for the first 6 hours after surgery. Time points were averaged for each participate and reported as a single value.</description>
          <population>Two participants in the intravenous acetaminophen group were discharged home prior to 6 hours after surgery and therefore were not included in the analysis.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.13" spread="1.36"/>
                    <measurement group_id="O2" value="1.36" spread="1.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.30</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Postoperative Pain: Standardized Pain Scale</title>
        <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) for the first 12 hours after surgery. Time points were averaged for each participate and reported as a single value.</description>
        <time_frame>The 12 hours following surgery</time_frame>
        <population>One participant in the rectal acetaminophen group, and 3 participants in the intravenous acetaminophen group were discharged home prior to 12 hours after surgery and therefore were not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Rectal Acetaminophen</title>
            <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain: Standardized Pain Scale</title>
          <description>Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) for the first 12 hours after surgery. Time points were averaged for each participate and reported as a single value.</description>
          <population>One participant in the rectal acetaminophen group, and 3 participants in the intravenous acetaminophen group were discharged home prior to 12 hours after surgery and therefore were not included in the analysis.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.99" spread="1.20"/>
                    <measurement group_id="O2" value="3.36" spread="1.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.43</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Opioid Use</title>
        <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 6 hours following surgery</description>
        <time_frame>The first 6 hours following surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rectal Acetaminophen</title>
            <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Use</title>
          <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 6 hours following surgery</description>
          <units>Morphine Milligram Equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.74" spread="7.49"/>
                    <measurement group_id="O2" value="7.97" spread="6.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.61</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Opioid Use</title>
        <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 12 hours following surgery</description>
        <time_frame>The first 12 hours following surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rectal Acetaminophen</title>
            <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Use</title>
          <description>Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 12 hours following surgery</description>
          <units>Morphine Milligram Equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.52" spread="13.35"/>
                    <measurement group_id="O2" value="14.17" spread="11.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.77</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Estimated Blood Loss</title>
        <description>Total estimated blood loss in millilitres for the surgery</description>
        <time_frame>During the duration of the surgery, from start to end time, on average 1.5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rectal Acetaminophen</title>
            <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Blood Loss</title>
          <description>Total estimated blood loss in millilitres for the surgery</description>
          <units>Millilitres</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="273.53" spread="138.20"/>
                    <measurement group_id="O2" value="347.37" spread="75.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.48</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Operative Time</title>
        <description>Operative time in minutes determined by the operating room record</description>
        <time_frame>From the start to end of the surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rectal Acetaminophen</title>
            <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Acetaminophen</title>
            <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Time</title>
          <description>Operative time in minutes determined by the operating room record</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.71" spread="24.22"/>
                    <measurement group_id="O2" value="90.89" spread="21.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From administration of acetaminophen until discharge from the hospital, up to 24 hours.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Rectal Acetaminophen</title>
          <description>Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.&#xD;
Rectal acetaminophen: Rectal 1300mg</description>
        </group>
        <group group_id="E2">
          <title>Intravenous Acetaminophen</title>
          <description>Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.&#xD;
Intravenous acetaminophen: Intravenous 1000mg</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Due to the COVID-19 pandemic, many patients were prohibited to stay overnight in the hospital. Therefore, many patients were discharged home before 24 hours after surgery. This is primarily why the primary and secondary outcomes were analyzed at shorter time intervals (6 hours post-op and 12 hours-op) as well.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Michaela Beynon</name_or_title>
      <organization>Aultman Hospital</organization>
      <phone>2488218826</phone>
      <email>michaelabeynon@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

